Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Stat1LoxP (Stat1 tm1Mam ) Mouse Model for Oncology and Immunology Studies
Case ID:
TAB-2406
Web Published:
12/6/2022
Selective inactivation of Stat1 in mammary cells indicates that its effect as a tumor suppressor in breast is direct.
STAT1 is considered a tumor suppressor, but it is not known if this effect occurs directly in mammary cells or secondarily by disrupting interferon signaling through the JAK/STAT1 pathway to induce immune responses. ERBB2/neu-induced breast cancer appeared sooner in mice lacking STAT1 only in mammary cells than in wild-type mice, indicating that STAT1 tumor suppression was intrinsic to mammary cells and not secondary to an induced immune response.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Stat1LoxP_(Stat1_tm1Mam_)_Mo use_Model_for_Oncology_and_Immunology_Studies
Keywords:
CCXXXX
CXXXXX
Mouse
STAT1
Stat1LoxP
Tm1Mam
Bookmark this page
Download as PDF
For Information, Contact:
Inteum Admin
NIH Technology Transfer